Login
Home / IBX.AX : ASX
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Imagion Biosystems Limited

AUD 0.01 -$0.02 (-69.23%)
ASX · 15 Sep 2026 05:59 UTC
Previous Close
AUD 0.01
Day Range
AUD 0.01 - AUD 0.01
Year Range
AUD 0.01AUD 0.06
Market Cap
4.32M
AVG Volume
2.65M
Trailing/Forward PE
-0.71/-
PEG ratio
-0.02
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
0500K1M1.5M2M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (AUD)
-8M-6M-4M-2M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (AUD)
-10M-7.5M-5M-2.5M02.5M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (AUD)
-8M-6M-4M-2M02M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (AUD)
-8M-6M-4M-2M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (AUD)
-0.3-0.2-0.1-021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (AUD)
-2.5M02.5M5M7.5M10MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (AUD)
05M10M15MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
-0.500.511.521 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
-3000%-2000%-1000%0%1000%20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
Return on Capital
-200%0%200%400%600%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
0200M400M600M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Book Value Per Share (AUD)
-0.200.20.40.621 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (AUD)
05M10M15M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Free Cash Flow Yield
-3000%-2000%-1000%0%med -182.61%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0123med 1.08Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
2468med 3.66Dec 21Apr 22Jul 22Nov 22Feb 23Jun 23Sep 23
Imagion Biosystems Limited
IBX.AX
Stockpicker

Video analysis: IBX.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IBX.AX

Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial

gurufocus.com · 25 Jun 2026

Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial

[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] announced that it has secured firm commitments for AU$3.75M (US$2.59M) in new capital following [url="]the FDA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.